Immunophenotype-guided interpretable radiomics model for predicting neoadjuvant anti-PD-1 response in stage III–IV d-MMR/MSI-H colorectal cancer
Background Neoadjuvant immunotherapy significantly improves the pathological complete response (pCR) rate in colorectal cancer (CRC). However, the lack of reliable tools to accurately identify responders remains a key barrier to its widespread clinical adoption. This study aimed to develop an interp...
Saved in:
| Main Authors: | Xuan Zhang, Zhenhui Li, Yiwen Zhang, Yanli Li, Xi Zhong, Wenjing Jiang, Xiaobo Chen, Zaiyi Liu, Liebin Huang, Caixia Zhang, Lizhu Liu, Ruimin You, Xiaoping Yi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/8/e011569.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
by: Ziyang Zeng, et al.
Published: (2025-05-01) -
Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI−H locally advanced colorectal cancer? a retrospective study
by: Zhenkai Luo, et al.
Published: (2025-08-01) -
Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
by: Zhu Xi, et al.
Published: (2024-02-01) -
Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report
by: Jiang Liu, et al.
Published: (2024-11-01) -
Application of peritumoral radiomics based on simulated positioning CT images in the prognosis of intermediate-advanced esophageal cancer
by: Ruiling Yang, et al.
Published: (2025-04-01)